dihydrotachysterol has been researched along with Hypothyroidism* in 7 studies
1 review(s) available for dihydrotachysterol and Hypothyroidism
Article | Year |
---|---|
Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.
Topics: Adult; Calcium; Carbimazole; Congenital Hypothyroidism; Dihydrotachysterol; Female; Humans; Hyperparathyroidism; Hyperthyroidism; Hypoparathyroidism; Hypothyroidism; Infant, Newborn; Parathyroid Diseases; Parathyroid Glands; Pregnancy; Pregnancy Complications; Propylthiouracil; Puerperal Disorders; Thyroid Diseases; Thyroxine | 1984 |
6 other study(ies) available for dihydrotachysterol and Hypothyroidism
Article | Year |
---|---|
Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation.
We treated a hypoparathyroid woman with calcitriol during pregnancy and did not reduce the dosage after delivery. Despite lactation, the serum calcium level increased to 15.4 mg/dL 11 days postpartum. We treated two other hypoparathyroid women during four pregnancies with either calcitriol or dihydrotachysterol. In all five pregnancies, requirements for the vitamin D preparations increased beginning at the 20-28th week of gestation. Hypercalcemia did not occur in the two women who did not breast-feed and in whom we reduced the dose of calcitriol or dihydrotachysterol after delivery. We conclude the following: 1) Calcitriol is effective for treating hypoparathyroidism during pregnancy; 2) the dose usually needs to be increased during the latter half of gestation; 3) the calcitriol dose should be reduced during lactation; and 4) both mother and infant should be monitored to detect hypercalcemia during breast-feeding. We speculate that low serum estrogen levels associated with breast-feeding promote bone resorption and diminish calcitriol needs in lactating hypoparathyroid women. Topics: Administration, Oral; Adult; Calcitriol; Calcium; Dihydrotachysterol; Female; Humans; Hypoparathyroidism; Hypothyroidism; Lactation; Pregnancy; Pregnancy Complications | 1990 |
Hypercalcaemia induced by increased thyroxine substitution in a patient treated with dihydrotachysterol.
The metabolism of vitamin D is essential in the control of bone and mineral metabolism. Hyperthyroidism as well as hypothyroidism effect the metabolism of bone tissue and vitamin D. We present a dihydrotachysterol-calcium treated patient with post-operative hypothyroidism, who developed hypercalcaemia, when the thyroxine dosage was increased. Topics: Calcium; Dihydrotachysterol; Female; Humans; Hypercalcemia; Hypocalcemia; Hypothyroidism; Middle Aged; Postoperative Complications; Thyroxine | 1984 |
Hypercalcaemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy.
Hypercalcaemia is a recognised complication of hypothyroidism. We describe three patients who developed hypercalcaemia after thyroidectomy when thyroid supplements were discontinued. They were treated with thyroxine, dihydrotachysterol, and calcium after operation, and in all three cases serum calcium concentrations remained constant during combined treatment. Thyroxine treatment was discontinued several weeks before a radioiodine scan was performed; dihydrotachysterol and calcium were continued throughout. Serum calcium concentrations rose to hypercalcaemic levels in all cases. Elimination of dihydrotachysterol from plasma may be delayed in hypothyroidism, resulting in hypervitaminosis D. It is advisable to reduce the dose of dihydrotachysterol and to check serum calcium concentrations regularly in patients whose thyroid treatment is interrupted. Topics: Adult; Calcium; Calcium Gluconate; Dihydrotachysterol; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hypothyroidism; Middle Aged; Thyroidectomy; Thyroxine | 1981 |
[Transitional symptoms, adverse effects and incidents in hormone-substitution therapy].
Patients underlying the permanent endocrine substitution need a particular control and a competent conduction on account of their endangering by intercurrent events. Highly specialised knowledge of the physician and intensive collaboration of the patient from this reciprocity lead to essential aspects of the prophylaxis of the crisis-like exacerbations exhibited in detail. The optimum substitution is supplemented by issuing information and emergency cards. When the patient possesses such cards they will become of decisive importance in an urgent therapy necessary outside the controlling facility. Topics: Arginine Vasopressin; Brain Edema; Diabetes Insipidus; Dihydrotachysterol; Humans; Hydrocortisone; Hypoparathyroidism; Hypothyroidism; Muscle Cramp; Pituitary Diseases; Thyroid Hormones; Vasopressins | 1976 |
The influence of thyroid hormone on calcium absorption from the gut in relation to urinary calcium excretion.
Topics: Calcium; Creatinine; Depression, Chemical; Dihydrotachysterol; Glomerular Filtration Rate; Humans; Hypoparathyroidism; Hypothyroidism; Intestinal Absorption; Myxedema; Phosphates; Phosphorus; Thyroidectomy; Triiodothyronine | 1973 |
Enhancement of calcium absorption in hypothyroidism. Observations with a new method measuring calcium absorption.
Topics: Calcium; Calcium Isotopes; Dihydrotachysterol; Humans; Hypoparathyroidism; Hypothyroidism; Myxedema; Thyroidectomy; Triiodothyronine | 1971 |